Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07209358 · ClinicalTrials.gov registry record · NA
EDX110 Randomized Control Trial for Treatment of DFUs
A NA study of Diabetic Foot Ulcer and Wound Heal, sponsored by ConvaTec.
- Recruiting
- Registry status
- NA
- Development phase
- 298
- Enrollment target
- 4
- Study locations
NCT07209358 is a NA study of Diabetic Foot Ulcer and Wound Heal that is actively recruiting participants, run by ConvaTec. The registered enrollment target is 298 participants, above the 251-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (19% higher). The trial reports 4 study locations across 3 states.
The verdict
NCT07209358, a NA study of Diabetic Foot Ulcer and Wound Heal, is actively recruiting participants, sponsored by ConvaTec.
- RECRUITING
- Registry status
- NA
- Development phase
- 298 participants
- Enrollment target
- 4
- Study locations
Study Summary
Prospective, multi-centered, observer blinded, pre-market study, 1:1 randomized control trial, to determine if addition of EDX110 dressing system to standard of care leads to an improvement in diabetic foot ulcers healing compared to just using standard of care.
Conditions Studied
Interventions
- DEVICE EDX110
Study Locations (4)
California
- Clemente Clinical Research - Santa Ana
- ILD Research Center - Vista
Arizona
- Axentra Bio - Phoenix
Texas
- Futuro Clinical Trials - McAllen
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 298 participants |
| Start Date | 2025-10-30 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07209358
The ClinicalTrials.gov registry entry for NCT07209358 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 298 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 251-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (19% higher). The listed sponsor is ConvaTec, which has 17 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 1 intervention - of which EDX110 is the first listed.
NCT07209358 reports 4 study locations spanning 3 distinct geographic areas - top geographies include California, Arizona, Texas.
Frequently Asked Questions
What is clinical trial NCT07209358 about?
NCT07209358 is a clinical study titled "EDX110 Randomized Control Trial for Treatment of DFUs". Prospective, multi-centered, observer blinded, pre-market study, 1:1 randomized control trial, to determine if addition of EDX110 dressing system to standard of care leads to an improvement in diabetic foot ulcers healing compared to just using standard of care.
What is the current status of trial NCT07209358?
This trial is currently recruiting. It is a NA study. The enrollment target is 298 participants. The study started on 2025-10-30. Estimated completion is 2026-12-31.
What conditions does trial NCT07209358 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Wound Heal.
What interventions are being tested in trial NCT07209358?
The interventions under investigation include: EDX110 (DEVICE).
Who is sponsoring clinical trial NCT07209358?
This trial is sponsored by ConvaTec, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07209358 being conducted?
This trial has 4 study locations across Arizona, California, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.